Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive subtype of ovarian malignancy. Its distinct biology requires a specific adjuvant treatment strategy that differs from conventional epithelial ovarian cancer regimens.
This protocol addresses patients with small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) — a rare, high-grade ovarian malignancy recognised as a distinct histological entity.
The recommended approach is adjuvant systemic therapy using intensive multi-agent combination chemotherapy regimens selected for this subtype.